Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maneesh Pingle

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2010
PCR/LDR/universal array platforms for the diagnosis of infectious diseaseManeesh Pingle, Mark Rundell, Sanchita Das, et al.
Bioconjugate Chemistry|August 19, 2010
Synthesis and evaluation of new spacers for use as dsDNA end-capsPei-Sze Ng, Brian M Laing, Ganesan Balasundarum, et al.
Pharmacology|August 23, 2018
A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Target-Directed Self-Assembly of Homodimeric Drugs Against β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Journal of Medicinal Chemistry|February 15, 2020
Novel, Self-Assembling Dimeric Inhibitors of Human β TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Diagnostic Microbiology and Infectious Disease|April 9, 2014
A multiplex PCR/LDR assay for simultaneous detection and identification of the NIAID category B bacterial food and water-borne pathogensMark S Rundell, Maneesh Pingle, Sanchita Das, et al.
Journal of Medicinal Chemistry|April 4, 2014
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosisPurong Zheng, Selin Somersan-Karakaya, Shichao Lu, et al.
European Journal of Medicinal Chemistry|February 22, 2014
Benzimidazole-based compounds kill Mycobacterium tuberculosisYaling Gong, Selin Somersan Karakaya, Xiaoyong Guo, et al.
Plos One|April 16, 2015
Reversible linkage of two distinct small molecule inhibitors of Myc generates a dimeric inhibitor with improved potency that is active in myc over-expressing cancer cell linesJutta Wanner, Darlene Romashko, Douglas S Werner, et al.
Journal of Medicinal Chemistry|May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosisBen Gold, Robert Smith, Quyen Nguyen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2010
PCR/LDR/universal array platforms for the diagnosis of infectious diseaseManeesh Pingle, Mark Rundell, Sanchita Das, et al.
Bioconjugate Chemistry|August 19, 2010
Synthesis and evaluation of new spacers for use as dsDNA end-capsPei-Sze Ng, Brian M Laing, Ganesan Balasundarum, et al.
Pharmacology|August 23, 2018
A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Target-Directed Self-Assembly of Homodimeric Drugs Against β-TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Journal of Medicinal Chemistry|February 15, 2020
Novel, Self-Assembling Dimeric Inhibitors of Human β TryptaseSarah F Giardina, Douglas S Werner, Maneesh Pingle, et al.
Diagnostic Microbiology and Infectious Disease|April 9, 2014
A multiplex PCR/LDR assay for simultaneous detection and identification of the NIAID category B bacterial food and water-borne pathogensMark S Rundell, Maneesh Pingle, Sanchita Das, et al.
Journal of Medicinal Chemistry|April 4, 2014
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosisPurong Zheng, Selin Somersan-Karakaya, Shichao Lu, et al.
European Journal of Medicinal Chemistry|February 22, 2014
Benzimidazole-based compounds kill Mycobacterium tuberculosisYaling Gong, Selin Somersan Karakaya, Xiaoyong Guo, et al.
Plos One|April 16, 2015
Reversible linkage of two distinct small molecule inhibitors of Myc generates a dimeric inhibitor with improved potency that is active in myc over-expressing cancer cell linesJutta Wanner, Darlene Romashko, Douglas S Werner, et al.
Journal of Medicinal Chemistry|May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosisBen Gold, Robert Smith, Quyen Nguyen, et al.
Pageof 2